1. Home
  2. WVE vs NWN Comparison

WVE vs NWN Comparison

Compare WVE & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$13.35

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

NWN

Northwest Natural Holding Company

N/A

Current Price

$52.03

Market Cap

2.1B

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
NWN
Founded
2012
1859
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil/Gas Transmission
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
WVE
NWN
Price
$13.35
$52.03
Analyst Decision
Strong Buy
Buy
Analyst Count
15
2
Target Price
$31.47
$52.50
AVG Volume (30 Days)
2.2M
256.7K
Earning Date
01-01-0001
06-01-2026
Dividend Yield
N/A
3.82%
EPS Growth
N/A
36.45
EPS
N/A
2.77
Revenue
$3,704,000.00
$1,289,363,000.00
Revenue This Year
N/A
$8.97
Revenue Next Year
$119.93
$4.27
P/E Ratio
N/A
$18.60
Revenue Growth
149.43
11.83
52 Week Low
$5.28
$38.94
52 Week High
$21.73
$53.66

Technical Indicators

Market Signals
Indicator
WVE
NWN
Relative Strength Index (RSI) 47.54 62.66
Support Level $12.53 $45.72
Resistance Level $14.56 $53.66
Average True Range (ATR) 0.79 1.31
MACD 0.01 -0.08
Stochastic Oscillator 23.84 67.21

Price Performance

Historical Comparison
WVE
NWN

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in one reportable business segment, which is NW Natural's local gas distribution business and is referred to as the NGD segment. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

Share on Social Networks: